{"id":"https://openalex.org/W2590935693","doi":"https://doi.org/10.1182/blood.v114.22.3461.3461","title":"CRLF2/JAK Signaling in Adult and Pediatric Acute Lymphoblastic Leukemia Is Highly Similar to BCR/ABL.","display_name":"CRLF2/JAK Signaling in Adult and Pediatric Acute Lymphoblastic Leukemia Is Highly Similar to BCR/ABL.","publication_year":2009,"publication_date":"2009-11-20","ids":{"openalex":"https://openalex.org/W2590935693","doi":"https://doi.org/10.1182/blood.v114.22.3461.3461","mag":"2590935693"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v114.22.3461.3461","doi":"https://doi.org/10.1182/blood.v114.22.3461.3461","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.3461.3461","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023995532","display_name":"Kartik M. Mani","orcid":"https://orcid.org/0000-0002-4951-3478","observed_orcids":["https://orcid.org/0000-0002-4951-3478"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kartik Mani","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069614210","display_name":"Akinori Yoda","orcid":"https://orcid.org/0000-0002-7806-1909","observed_orcids":["https://orcid.org/0000-0002-7806-1909"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Akinori Yoda","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041181079","display_name":"Sabina Chiaretti","orcid":"https://orcid.org/0000-0001-8499-4492","observed_orcids":["https://orcid.org/0000-0001-8499-4492"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Sabina Chiaretti","raw_affiliation_strings":["Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy,","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009431453","display_name":"Robin Fo\u00e0","orcid":"https://orcid.org/0000-0002-5021-3026","observed_orcids":["https://orcid.org/0000-0002-5021-3026"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Robin Foa","raw_affiliation_strings":["Division of Hematology, University \u201cLa Sapienza\u201d, Rome, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University \u201cLa Sapienza\u201d, Rome, Italy,","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026688095","display_name":"David M. Weinstock","orcid":"https://orcid.org/0000-0002-8724-3907","observed_orcids":["https://orcid.org/0000-0002-8724-3907"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M Weinstock","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5009431453","https://openalex.org/A5023995532","https://openalex.org/A5041181079","https://openalex.org/A5069614210"],"corresponding_institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I861853513"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.39423064,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"114","issue":"22","first_page":"3461","last_page":"3461"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crlf2","display_name":"CRLF2","score":0.9430000185966492},{"id":"https://openalex.org/keywords/jak-signaling","display_name":"JAK signaling","score":0.9539999961853027},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.871999979019165},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.7080000042915344},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.7480000257492065},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.5839999914169312},{"id":"https://openalex.org/keywords/differentially-expressed-genes","display_name":"differentially expressed genes","score":0.722000002861023},{"id":"https://openalex.org/keywords/gene-set-enrichment-analysis","display_name":"gene set enrichment analysis","score":0.5979999899864197},{"id":"https://openalex.org/keywords/high-risk-leukemia","display_name":"high-risk leukemia","score":0.4269999861717224},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.5839999914169312},{"id":"https://openalex.org/keywords/crlf2-overexpression","display_name":"CRLF2 overexpression","score":0.5809999704360962},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.46399998664855957},{"id":"https://openalex.org/keywords/transcriptional-dysregulation","display_name":"transcriptional dysregulation","score":0.4830000102519989},{"id":"https://openalex.org/keywords/igh-translocation","display_name":"IGH translocation","score":0.47600001096725464},{"id":"https://openalex.org/keywords/interstitial-deletion","display_name":"interstitial deletion","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.6409043073654175},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.48978424072265625},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4860432744026184},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.47932517528533936},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.4758995473384857},{"id":"https://openalex.org/C84597430","wikidata":"https://www.wikidata.org/wiki/Q106227","display_name":"Locus (genetics)","level":3,"score":0.45319095253944397},{"id":"https://openalex.org/C95371953","wikidata":"https://www.wikidata.org/wiki/Q591745","display_name":"DNA microarray","level":4,"score":0.4441136121749878},{"id":"https://openalex.org/C2779018089","wikidata":"https://www.wikidata.org/wiki/Q17014303","display_name":"Fold change","level":4,"score":0.43165135383605957},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4255937933921814},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4205598533153534},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3506515324115753},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32776033878326416},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.31736162304878235}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v114.22.3461.3461","doi":"https://doi.org/10.1182/blood.v114.22.3461.3461","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.3461.3461","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3121557180","https://openalex.org/W3157789330","https://openalex.org/W4385658115","https://openalex.org/W2036999612","https://openalex.org/W4391713881","https://openalex.org/W2280711224","https://openalex.org/W4200597599","https://openalex.org/W2076071435","https://openalex.org/W2233230192","https://openalex.org/W1997941143"],"abstract_inverted_index":{"Abstract":[0,1],"3461":[2],"Poster":[3],"Board":[4],"III-349":[5],"Introduction":[6],"We":[7,111],"and":[8,54,87,103,132,171,202,283,291,311,339,365,442,444,477],"others":[9],"recently":[10],"identified":[11,133],"the":[12,37,92,99,113,121,127,154,168,176,247,276,300,358,379,416,447],"type":[13],"I-like":[14],"cytokine":[15],"receptor":[16],"CRLF2":[17,62,108,128,157,192,266,307,317,330,394,435],"as":[18,161,191],"an":[19],"oncoprotein":[20],"in":[21,91,275,319,332,336,362,378,421,426,452],"precursor":[22],"B-cell":[23],"acute":[24],"lymphoblastic":[25],"leukemia":[26],"(B-ALL).":[27],"Overexpression":[28],"of":[29,197,258,272,302,306,325,350,387,398,415,450,484],"CRLF2,":[30],"which":[31],"can":[32],"occur":[33],"through":[34],"translocation":[35],"to":[36,45,68,97,208,241,486],"IGH":[38],"locus":[39],"or":[40],"interstitial":[41],"deletion,":[42],"is":[43,437,459],"confined":[44],"B-ALL":[46,59,117,260,334],"that":[47,60,73,156,251,261,279,466],"lack":[48],"rearrangements":[49,264],"involving":[50],"MLL,":[51],"E2A,":[52],"TEL,":[53],"BCR/ABL.":[55],"Importantly,":[56],"adults":[57],"with":[58,70,107,214,222,269,316,329,353,434,446,462],"overexpress":[61,76],"have":[63],"reduced":[64],"disease-free":[65],"survival":[66],"compared":[67,221,268],"patients":[69,236,285,389],"similar":[71,439],"karyotypes":[72],"do":[74],"not":[75],"CRLF2.":[77,215],"In":[78],"this":[79],"study,":[80],"we":[81],"used":[82],"high-throughput":[83],"gene":[84],"expression":[85,225,423,431],"microarrays":[86],"publicly":[88],"available":[89,240],"data":[90,234,372],"Gene":[93,228],"Expression":[94],"Omnibus":[95],"(GEO)":[96],"characterize":[98],"epidemiology,":[100],"transcriptional":[101],"signatures":[102,226,345,424],"dysregulated":[104],"pathways":[105,468],"associated":[106,213,315,328,352,433,461],"overexpression.":[109],"Methods":[110],"searched":[112],"GEO":[114],"for":[115,167,175,295],"pediatric":[116,249,288,344],"cases":[118,199,274,309],"profiled":[119],"on":[120,153,299,373],"Affymetrix":[122],"U133":[123],"platforms":[124],"(which":[125],"contain":[126],"probe":[129],"set":[130],"208303_s_at)":[131],"9":[134],"applicable":[135],"datasets":[136,144,250,278,289,321],"(3":[137],"exclusively":[138],"high-risk),":[139],"totaling":[140],"1,253":[141],"samples.":[142],"These":[143],"were":[145,189,200,293,382],"individually":[146],"normalized":[147],"using":[148,227],"robust":[149],"multi-array":[150],"average.":[151],"Based":[152],"assumption":[155],"over-expression":[158],"would":[159],"manifest":[160],"a":[162,172,185,203,303,326],"bimodal":[163],"distribution":[164],"(one":[165],"peak":[166,174],"background":[169,187],"levels":[170],"smaller":[173],"overexpressed":[177],"levels),":[178],"points":[179],"falling":[180],"5":[181],"standard":[182],"deviations":[183],"outside":[184],"computed":[186],"mean":[188],"selected":[190,201,294],"positive.":[193],"An":[194],"equal":[195],"number":[196],"underexpressed":[198],"student":[204],"t-test":[205],"was":[206,220,237,409],"applied":[207],"identify":[209],"differentially":[210],"expressed":[211],"genes":[212,351],"The":[216,430,456],"resultant":[217],"ranked":[218],"list":[219],"several":[223],"other":[224],"Set":[229],"Enrichment":[230],"Analysis":[231],"(GSEA).":[232],"Sequencing":[233],"from":[235,357,475],"integrated":[238],"where":[239],"obtain":[242],"genetic-genomic":[243],"associations.":[244],"Results":[245],"Among":[246],"3":[248],"included":[252,280],"only":[253],"high-risk":[254,284,448],"patients,":[255],"52":[256],"(14.8%)":[257],"351":[259],"lacked":[262],"characteristic":[263],"had":[265,393],"overexpression,":[267],"23":[270],"(4.1%)":[271],"559":[273],"six":[277],"both":[281,337,343,363,422,453],"standard-risk":[282],"(p<0.0001).":[286],"Two":[287],"(GSE11877":[290],"GSE12995)":[292],"supervised":[296],"analysis":[297],"based":[298],"presence":[301],"clear":[304],"subset":[305],"overexpressing":[308],"(n=29":[310],"n=8":[312],"respectively).":[313],"Genes":[314],"overexpression":[318,331,436],"these":[320],"showed":[322,346],"significant":[323],"enrichment":[324,349,414],"signature":[327,432,458],"adult":[333],"(p<0.001":[335,361,425],"up-regulated":[338,427],"down-regulated":[340,366],"sets).":[341,367,428],"Furthermore,":[342],"similarly":[347],"striking":[348],"BCR/ABL-expressing":[354,463],"B-ALL,":[355,464],"obtained":[356],"Oncomine\u00ae":[359],"database":[360],"up-":[364],"Lastly,":[368],"when":[369],"previously":[370],"published":[371],"Janus":[374],"kinase":[375,473],"(JAK)":[376],"mutations":[377,392,402],"GSE11877":[380],"cohort":[381],"integrated,":[383],"18":[384],"(90%)":[385],"out":[386],"20":[388],"harboring":[390,400],"JAK":[391],"over-expression;":[395],"16":[396,399],"(100%)":[397],"JAK2":[401],"(p=0,":[403],"below":[404],"machine":[405],"precision).":[406],"This":[407],"result":[408],"further":[410],"supported":[411],"by":[412,471],"strong":[413],"JAK-STAT":[417],"signaling":[418,474],"pathway":[419],"(KEGG)":[420],"Conclusions":[429],"highly":[438],"between":[440],"children":[441],"adults,":[443],"consistent":[445],"nature":[449],"disease":[451],"age":[454],"groups.":[455],"same":[457],"strongly":[460],"suggesting":[465],"overlapping":[467],"are":[469],"activated":[470],"tyrosine":[472],"BCR/ABL":[476],"mutated":[478],"CRLF2/JAK.":[479],"Disclosures":[480],"No":[481],"relevant":[482],"conflicts":[483],"interest":[485],"declare.":[487]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-03-03T00:00:00"}